Cowealth Medical China Co.Ltd. (603122) — Capital Reinvestment Ratio
Cowealth Medical China Co.Ltd. (603122) has a Capital Reinvestment Ratio of 0.80x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥17.68 Million) in capital expenditures (CN¥14.21 Million). See Cowealth Medical China Co.Ltd. balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cowealth Medical China Co.Ltd. Capital Reinvestment Ratio (2020–2025)
This chart tracks Cowealth Medical China Co.Ltd.'s Capital Reinvestment Ratio across 5 annual periods. Check Cowealth Medical China Co.Ltd. (603122) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Cowealth Medical China Co.Ltd. (2020–2025)
Year-by-year Capital Reinvestment Ratio for Cowealth Medical China Co.Ltd. from 2020 to 2025. For live market cap and broader valuation context, see Cowealth Medical China Co.Ltd. market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.80x | CN¥17.68 Million | CN¥14.21 Million | ▲ +235.2% |
| 2024 | 0.24x | CN¥132.75 Million | CN¥31.82 Million | ▼ -96.0% |
| 2023 | 6.02x | CN¥11.28 Million | CN¥67.96 Million | ▲ +90.9% |
| 2021 | 3.16x | CN¥7.01 Million | CN¥22.12 Million | ▲ +2785.6% |
| 2020 | 0.11x | CN¥74.15 Million | CN¥8.11 Million | — |